Cristina Matteo

6PUBLICATIONS
51CO-AUTHORS
Infant and child healthNeonatologyPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 19, 2025
PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia Treated within the AIEOP-BFM ALL 2009 Trial: Population Pharmacokinetics and Drug Exposure.

Gudrun Würthwein, Christian Siebel, Claudia Lanvers-Kaminsky

|Jul 30, 2025
Pharmacokinetics of Pegaspargase with a Limited Sampling Strategy for Asparaginase Activity Monitoring in Children with Acute Lymphoblastic Leukemia.

Cristina Matteo, Antonella Colombini, Marta Cancelliere

|Mar 28, 2024
Validated LC-MS/MS Assay for the Quantitative Determination of Fenretinide in Plasma and Tumor and Its Application in a Pharmacokinetic Study in Mice of a Novel Oral Nanoformulation of Fenretinide.

Cristina Matteo, Isabella Orienti, Adriana Eramo

|Dec 14, 2023
Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study.

Valentino Conter, Maria Grazia Valsecchi, Gunnar Cario

|Aug 04, 2023
Chemotherapy-induced neutropenia elicits metastasis formation in mice by promoting proliferation of disseminated tumor cells.

Massimo Russo, Nicolò Panini, Paola Fabbrizio

|May 13, 2022
Pharmacological and clinical monitoring in children with acute lymphoblastic leukemia treated with a biogeneric PEG-l-asparaginase product.

Cristina Matteo, Antonella Colombini, Laura Rachele Bettini

Pageof 1

Frequent Collaborators

4 joint publications

Massimo Zucchetti

3 joint publications

Carmelo Rizzari

2 joint publications

Martin Schrappe

2 joint publications

Petr Smisek